ArticleJournal of inflammation research2026

Tocilizumab for the Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease in Children: Two Case Reports and Literature Review.

Li-E Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.